(Q35597876)

9 August 2017

title

The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans (English)

1 reference

9 August 2017

0 references

1 reference

1 reference

Daniel Shriner

6

0 references

Adebowale A. Adeyemo

object named as

Adebowale Adeyemo

series ordinal

7

0 references

Charles Rotimi

series ordinal

8

object named as

Charles N Rotimi

1 reference

9 August 2017

2

Ayo Doumatey

1 reference

9 August 2017

5

Guanjie Chen

1 reference

9 August 2017

3

Hanxia Huang

1 reference

9 August 2017

1

Bashira A Charles

1 reference

9 August 2017

Jie Zhou

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

28 September 2011

1 reference

The Journal of Clinical Endocrinology and Metabolism

9 August 2017

published in

1 reference

9 August 2017

volume

96

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

E2018-22

1 reference

Insulin resistance predicts mortality in nondiabetic individuals in the U.S.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Relationships among obesity, inflammation, and insulin resistance in african americans and west africans

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

The role of interleukins in insulin resistance and type 2 diabetes mellitus.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Inflamed adipose tissue, insulin resistance and vascular injury

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Adipose tissue: a regulator of inflammation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Inflammation, stress, and diabetes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Insulin resistance. Prosperity's plague.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Raised interleukin-6 levels in obese patients.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232609

Adipose tissue is a regulated source of interleukin-10

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21956416

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21956416

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1210/JC.2011-1497

1 reference

9 August 2017

1 reference

9 August 2017

1 reference